Federal Register #2026-12653

DEA Correction to Bromazolam Schedule I Placement – No Procurement Activity

This notice is a regulatory correction issued by the Drug Enforcement Administration (DEA), part of the Department of Justice. - The correction updates the chemical name for bromazolam in its Schedule I placement under the Controlled Substances Act - No procurement activity is involved; this is not a solicitation for products or services - No OEMs, vendors, or commercial products are referenced - The notice is strictly regulatory and does not request or announce the purchase of any goods or services

Description

This document is a correcting amendment issued by the Drug Enforcement Administration (DEA) to correct an invalid chemical name for bromazolam in a temporary order published on March 16, 2026. The amendment adds the valid chemical name for bromazolam, which is placed in Schedule I of the Controlled Substances Act. The correction is effective June 24, 2026, and applicable beginning March 16, 2026. The DEA is the procuring agency responsible for this regulatory action.

View original listing